Cumberland Pharmaceuticals, Inc. (CPIX) Misses Q1 EPS by 3c

Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) reported Q1 EPS of $0.02, $0.03 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $10.3 million versus the consensus estimate of $12.87 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals, Inc. (CPIX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• UBS Reiterates Neutral Rating on Lennar (LEN) Following Q2 Results
• United Community Banks sells equipment finance unit for $1.9 billion